Radiopharm Theranostics (RADX) Equity Ratio (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Equity Ratio for 2 consecutive years, with 0.5 as the latest value for Q2 2025.
- On a quarterly basis, Equity Ratio rose 30.55% to 0.5 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.5, a 30.55% increase, with the full-year FY2025 number at 0.5, up 30.55% from a year prior.
- Equity Ratio was 0.5 for Q2 2025 at Radiopharm Theranostics, up from 0.38 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.5 in Q2 2025 to a low of 0.38 in Q2 2024.